Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

Intellectual Property and Trade

  • your selections
Clear Search

Filter Results

date

Tags

  • results
GlaxoSmithKline’s HIV/AIDS Business Joins Medicines Patent Pool

“GlaxoSmithKline’s HIV/AIDS drugs business is to share intellectual property rights on children’s medicine in a patent pool designed to make treatments more widely available in poor countries,” Reuters reports. “ViiV Healthcare, majority-owned by GSK, is the second research-based pharmaceutical business to sign up to the new Medicines Patent Pool, following a lead set in…

President Obama Delivers SOTU Address, Mentioning Trade Agreements, AIDS-Free Generation

“President Barack Obama outlined an ambitious agenda in his State of the Union address Tuesday that included raising the minimum wage, increasing spending on infrastructure, attacking climate change and passing gun-control legislation,” the Wall Street Journal reports (2/13). “Obama used his State of the Union address Tuesday night to urge the United States to…

UNAIDS, UNDP Release Issue Brief On TRIPS Transition Period Extensions For LDCs

“The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Development Programme (UNDP) today launched a new issue brief” (.pdf), titled “TRIPS transition period extensions for least-developed countries [LDCs],” a UNAIDS press release reports. “The issue brief outlines that failure to extend the transition period for least-developed countries to become fully…

HHS Global Health Official Discusses Tobacco-, Drug Patent-Related Trade Negotiations

Inside U.S. Trade features an interview with HHS Assistant Secretary for Global Affairs Nils Daulaire, who discusses how “the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for…

India’s Supreme Court Rules Against Novartis AG In ‘Landmark’ Patent Case

“India’s Supreme Court on Monday rejected drug maker Novartis AG’s attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines,” the Associated Press reports. “Novartis had…

WTO’s TRIPS Council Grants Extension To World’s Poorest Nations

“The globe’s poorest nations have won an eight-year extension of a waiver on intellectual property rules, but still need to hold talks on the vexed issue of pharmaceutical patents, World Trade Organization [WTO] officials said Tuesday,” Agence France-Presse/GlobalPost reports. “A session of the 159-nation WTO’s TRIPS Council — standing for…

International Organization Leaders Discuss Medical Innovation At Symposium

“The leaders of three top international organizations in Geneva last week discussed synergies in public health and called for increased collaboration and creativity to [improve] medical innovation,” Intellectual Property Watch reports. “The directors general of the WHO, World Trade Organization and World Intellectual Property Organization addressed the [July 5] opening…

Media Outlets Examine Reaction To India’s Supreme Court Ruling On Novartis Patent Case

“In a decisive victory for India’s pharmaceutical industry, India’s Supreme Court rejected Novartis’ patent application for the cancer drug Glivec on Monday, ending a seven-year battle by the Swiss drug maker to get a patent in India on its powerful leukemia drug,” Time reports (Mahr, 4/1). “The decision means generic…